NCT07417904
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Recruiting · Not Applicable · Howard University · registry updated 2026-07-29
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Inclusion
- Young adults aged 16-30 years
- Diagnosis of early psychosis
- Currently receiving outpatient care through an early psychosis clinic
- Psychiatrically stable and deemed appropriate for participation by a treating clinician
- Able and willing to provide informed consent
Exclusion
- Unable to provide informed consent
- Not fluent in English
- History of antisocial behavior, as assessed at baseline
- Immediate risk requiring a higher level of care